The following is a summary of the financial results as of June 30, 2013 and 2012, and for the year then ended: Summary Selected Financial DataStatement of Operations Highlights20132012Net sales
29,538,27531,664,181Cost of sales18,451,67319,720,948Gross profit11,086,60211,943,233Selling, general, and administrative expenses9,860,96410,506,460Research and development expenses1,120,8871,410,406Total other expense235,876216,608Loss before income tax benefit (131,125)(190,241)Income tax benefit 86,754166,706Net loss
(44,371)(23,535)Diluted net loss per common share
(0.02)(0.01) Balance Sheet Highlights20132012Cash and cash equivalents
302,050278,263Trade accounts receivable3,246,7123,667,086Inventories, net6,407,5536,098,597Total current assets10,879,44910,654,158Total assets
15,104,58715,270,930Line of credit3,496,3903,497,597Accounts payable2,751,8942,413,201Accrued expenses347,221386,229Accrued payroll and benefits expense216,266215,218Total liabilities8,895,6379,004,615Total liabilities and stockholders' equity
15,104,58715,270,930Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.
This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding expectations for future new product introduction
|SOURCE Dynatronics Corporation|
Copyright©2012 PR Newswire.
All rights reserved